12:00 AM
 | 
May 11, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Status

ARRY-162: Completed Phase II enrollment

Array completed enrollment of 201 patients in a 12-week, double-blind, placebo-controlled, international Phase II trial (162-201) evaluating 10 and 20 mg of oral ARRY-162...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >